20 Participants Needed

Surgical Sectioning for Tethered Cord Syndrome

(OCCULT Trial)

MT
JG
Overseen ByJeffrey Greenfield, MD, PhD
Age: Any Age
Sex: Any
Trial Phase: Phase 2
Sponsor: Weill Medical College of Cornell University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether surgery is more effective than medicine for treating Occult Tethered Cord Syndrome (OTCS), a condition where the spinal cord is abnormally attached, causing pain and other issues. The main treatment under evaluation is a surgery called "Release of filum terminale," which releases fibrous tissue at the end of the spinal cord to determine if it more effectively relieves symptoms. Participants will either undergo the surgery or continue with medical management to compare results. Ideal candidates have experienced symptoms that have not improved with medicine for at least a year and have been diagnosed with OTCS. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group of people.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that the surgical sectioning for tethered cord syndrome is safe?

Research has shown that surgery to release the filum terminale, a tissue strand at the end of the spinal cord, is generally safe for treating tethered cord syndrome. Studies have found that this surgery effectively improves symptoms for most patients, with many experiencing significant relief.

Most surgeries yield good results with few complications. However, the procedure carries a risk of injuring nearby nerves. Despite this risk, careful monitoring during surgery helps reduce potential harm. Overall, patients generally tolerate the surgery well, and the benefits often outweigh the risks.12345

Why do researchers think this study treatment might be promising?

Researchers are excited about the release of the filum terminale for tethered cord syndrome because it offers a direct surgical approach to alleviate tension on the spinal cord. Unlike standard treatments, which often focus on symptomatic relief or less invasive monitoring, this surgical method aims to directly address the root cause of the syndrome by cutting the filum terminale, a fibrous band that can restrict spinal cord movement. This approach could potentially provide more lasting relief from symptoms and improve quality of life for patients.

What evidence suggests that surgical sectioning is effective for Occult Tethered Cord Syndrome?

Research has shown that surgery to release the filum terminale can effectively treat tethered cord syndrome. In this trial, participants may undergo this surgical procedure. Studies have found that patients who underwent this surgery often experienced significant relief from their symptoms, especially those related to hypermobile Ehlers-Danlos syndrome (hEDS). Previous research suggests that surgery might be more effective than medication alone in managing symptoms of occult tethered cord syndrome (OTCS). This type of surgery is generally considered safe and offers a promising option for people with OTCS.12367

Who Is on the Research Team?

JG

Jeffrey Greenfield, MD, PhD

Principal Investigator

Weill Medical College of Cornell University

Are You a Good Fit for This Trial?

This trial is for people aged 2 to 79 with Occult Tethered Cord Syndrome (OTCS) who haven't improved after at least a year of medical treatment. They must score at least 30 on the OCCULT Grading Scale. It's not for those with visible signs of spinal issues, previous lumbar spine or spinal dysraphism surgeries, or a history of central nervous system infections or autoimmune diseases.

Inclusion Criteria

You have been diagnosed with Tethered Cord Syndrome
You have a total score of at least 30 on the OCCULT Grading Scale, which measures a type of skin condition.
I am between 2 and 79 years old.
See 1 more

Exclusion Criteria

I have a history of spinal cord issues related to Meningocele or Myelomeningocele.
I have had surgery on my lower back before.
I have visible skin markings indicating a dermal sinus tract.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomized to either surgical untethering of the filum terminale or medical management

1 year
Regular visits for symptom assessment and adverse event monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Crossover

Subjects in the medical management arm may cross over to the surgical arm if deemed beneficial

After 1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Release of filum terminale
Trial Overview The study tests if cutting the filum terminale—a fibrous tissue at the end of the spinal cord—is better than standard medical care in relieving symptoms of OTCS. The hypothesis suggests surgery could be more effective and that benefits may outweigh risks.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: SurgeryActive Control1 Intervention
Group II: ObservationActive Control1 Intervention

Release of filum terminale is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Filum Terminale Release for:
🇪🇺
Approved in European Union as Filum Terminale Release for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

Published Research Related to This Trial

In a study of 152 patients who underwent section of a tight filum terminale, 8.6% experienced symptomatic retethering, with a median time of 23.4 months post-surgery, indicating that retethering is a notable risk even after this minimally invasive procedure.
Two patterns of retethering were identified: early retethering was associated with older age at surgery and more complications like arachnoiditis, while late retethering was linked to younger patients who had surgery earlier to prevent tethered cord symptoms.
Symptomatic retethering of the spinal cord after section of a tight filum terminale.Yong, RL., Habrock-Bach, T., Vaughan, M., et al.[2011]
The liver hanging maneuver (LHM) was associated with lower intraoperative blood loss and no need for blood transfusions in patients undergoing anatomical hepatectomy for large liver tumors, suggesting it may enhance safety during surgery.
Patients who underwent LHM had a shorter hospital stay and did not experience post-hepatectomy liver failure or bile leakage, indicating improved outcomes compared to those who did not receive the maneuver.
Liver hanging maneuver is suitable in major hepatectomy for liver malignancies over 5 cm.Nanashima, A., Hiyoshi, M., Imamura, N., et al.[2023]
The modified hanging maneuver using the Goldfinger dissector in laparoscopic liver resection was performed on 18 patients, demonstrating a median resection time of 96 minutes and minimal blood loss of 220 ml, indicating its efficacy and safety.
Only two complications (11%) were reported, which resolved spontaneously, suggesting that this technique is safe for use in major hepatectomies without the need for conversion to open surgery.
Modified hanging maneuver using the goldfinger dissector in laparoscopic right and left hepatectomy.Troisi, RI., Montalti, R.[2019]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/35663696/
Patient-Reported Outcomes Following Sectioning of the ...Surgical release of the FT for TCS in patients with hEDS was safe and effective in this cohort. For most patients, there was a significant improvement in low ...
Patient-Reported Outcomes Following Sectioning of the ...Surgical release of the FT for TCS in patients with hEDS was safe and effective in this cohort. For most patients, there was a significant improvement in low ...
Investigation of Surgical Sectioning of the Filum Terminale ...The exploratory hypothesis is that surgery for OTCS is both safe and more effective than medical management at relieving the symptoms of OTCS. Official Title.
Diseased Filum Terminale as a Cause of Tethered Cord ...We hypothesized that a diseased filum terminale (FT) might cause TCS in hEDS, justifying surgical transection for treatment.
Clinical criteria for filum terminale resection in occult ...The authors aimed to improve the diagnosis of occult tethered cord syndrome and assess outcome following filum terminale resection. Based on ...
Neurophysiological monitoring for safe surgical tethered ...Release of tethered spinal cord by sectioning of the filum terminale carries a significant risk of injury to the neighboring motor and sensory nerve roots.
Pediatric tethered cord release: an epidemiological and ...Typically the filum is identified, coagulated, and cut, with satisfactory outcomes and overall low rate of complication pending the underlying pathology.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security